Early bone drug study for ACL injuries halted after just 4 people
NCT ID NCT05204836
First seen Jan 05, 2026 · Last updated Apr 28, 2026 · Updated 16 times
Summary
This small, early-stage study tested whether a single injection of zoledronic acid (a bone-strengthening drug) could change bone structure after an ACL tear and possibly prevent future knee arthritis. Only 4 people with a recent ACL tear took part. The study was stopped early, so we don't have clear answers on whether the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTERIOR CRUCIATE LIGAMENT TEAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
Conditions
Explore the condition pages connected to this study.